APM Competitors & Alternatives

Compare Aptorum Group Ltd Class A with similar stocks in the same industry

Biotechnology

APM

Main Stock
$0.70
+1.10%
Tradestie Score
46
Market Cap
$15.57M
Revenue Growth
-100.0%
Analyst Upside
+11328.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Smart-ACT platform, drug repurposing algorithms, small molecule screening
Major Customers 5
pharmaceutical partners research institutions specialty hospitals clinical trial sites biotech collaborators
Critical Suppliers 5
CROs API manufacturers preclinical labs regulatory consultants academic research centers
Direct Ecosystem Rivals 4

Top Competitors

224 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ANRO Alto Neuroscience Inc.
$29.54
-3.53%
$110.20M - 35 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.11
-3.42%
$84.52M - 47 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.84
-2.85%
$67.94M - 48 Compare
LMFA LM Funding America, Inc. Common Stock
$2.60
+6.12%
$18.31M - 37 Compare
PULM Pulmatrix, Inc. Common Stock
$1.29
-0.76%
$17.88M - 34 Compare
MEIP MEIP
- - - 49 Compare
GRTX GRTX
- - - - Compare
OTRK OTRK
- - - - Compare
SRNE SRNE
- - - - Compare
ONCT ONCT
- - - - Compare

Data updated: Nov 15, 2026 | Industry: Biotechnology (SIC 3829)

224 stocks in this industry